Boehringer Ingelheim

Robotic hand stacking coins

Biotech

With $15M, BI becomes latest to buy into Immunai’s AI platform

The team-up will start by harnessing Immunai’s single-cell AI platform to analyze T cells from patients with various cancers and autoimmune diseases.

Darren Incorvaia Jun 25, 2026 9:00am

lung cancer

Guardant Health nabs FDA test approval for BI's new cancer drug

Jun 12, 2026 9:47am

Boehringer Ingelheim ADA2026 BI

ADA: Tolerability questions linger for Boehringer's obesity drug

Jun 8, 2026 4:30am

Berlin Germany Brandenburg Gate

Fierce Pharma

Lilly, Boehringer slash investment plans in Germany

Jun 3, 2026 3:10pm

Three blocks displaying from left to right a person a handshake and another person

Boehringer makes €407M bet on Immunitas’ inflammatory asset

May 12, 2026 9:57am

obesity overweight weight loss weigh

Boehringer links dual agonist to 16.6% weight loss in phase 3

Apr 28, 2026 4:00am